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synthesis directly and limit any subsequent increase in 
total body levels of potassium,5 but potassium-mediat- 
ed mineralocorticoid production by the adrenal re- 
quires the presence of angiotensin II and does not 
occur during converting-enzyme inhibition.6 Conse- 
quently, the excretion of potassium becomes notably 
impaired during captopril therapy, and therefore, se- 
rum potassium concentration varies directly with 
changes in dietary potassium. Hyperkalemia may re- 
sult if potassium intake is increased [either by the ad- 
ministration of prescribed potassium supplements or 
by the use of potassium-containing salt substitutes) or 
the renal excretion of potassium is further impaired 
[by treatment with potassium-sparing diuretics or by 
decreases in glomerular filtration rate).2 On the other 
hand, hypokalemia can occur in patients being treated 
with diuretic drugs if the renal disposal of potassium is 
restored by the withdrawal of converting-enzyme ind 
hibition and dietary potassium is not supplemented. 
Although in most cases changes in serum potassium 
concentration are small, our findings indicate that in 
some patients, hypokalemia or hyperkalemia may be 
sufficiently severe to cause cardiac arrest. Hence, we 
recommend close attention to and reevaluation of di- 
etary potassium intake and prescribed potassium sup- 
plementation whenever treatment with converting- 
enzyme inhibitors is instituted or discontinued. 
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B alloon dilation has been used successfully to treat 
many forms of congenital heart disease.’ Inoue et al2 
reported in 6 adults the successful use of a specially 
designed balloon catheter to treat rheumatic mitral 
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stenosis (MS). This report describes balloon angio- 
plasty in 2 children with congenital MS and in 1 ado- 
lescent with rheumatic MS. 
Case 1: P.P., an l&year-old woman with rheumatic 
MS, underwent cardiac catheterization on Ianuary 28, 
1984 because of severe dyspnea and chest pain. Cathe- 
terization revealed severe MS, mild aortic stenosis 
and regurgitation and mild pulmonary hypertension. 
After the patient was informed that balloon dilation of 
the mitral valve was an experimental but potentially 
therapeutic alternative to surgical mitral commissur- 
otomy, she consented to the procedure. On February 
6.1984, using the percutaneous femoral approach, pre- 
dilation hemodynamics and angiography were per- 
formed (Table I, Fig. 1). The balloon dilation was per- 
formed as follows: The left atrium was entered with a 
No. 8Fr Mullins transeptal sheath. After hepariniza- 
tion, a No. 7Fr wedge catheter was positioned into the 
left ventricle. A &(%-inch 1 exchange (250 cm] guide- 
wire was advanced through the wedge catheter into 
the left ventricular apex. The wedge catheter and 
sheath were removed and a No. 9Fr angioplasty cath- 
TABLE I Hemodynamlc Data Before and After Angioplasty 
Mitral aalloorl PA LA (mm W 
Age Anulw SiZE sld (m) Cl 
W Size (mm) (mm) (mm He) a-wave Maan (Ilters/mln/m*) 
Patient 1 
Before 17 20 20 49120 (34) 36 24 0.95 3.2 
After 30119 (28) 20 10 1.25 2.9 
Patient 2 
Before 13 18 15 70136 (54) 39 32 0.70 3.3 
After 52/37 (40) 28 21 0.95 3.3 
After = after angioplasty; Before = before angioplasty; Cl = cardiac index (thermodllutlon); LA G left atrlal presswe; m = mean; MVA = mitral vahre area (Gor- 
lin and Gcrlin formula); PA = puhnonary artery pressure; s/d = peak systollchd diastolic. 
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TABLE II Two-Dimenslonal Echocardlcgraphlc and Doppler Data 
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eter with a Z&mm balloon (Medi-Tech) was posi- 
tioned across the mitral valve. The balloon was inflat- 
ed to 4 atm for less than IO seconds. During the 
procedure left ventricular and pulmonary artery 
pressures and heart rate were continuously moni- 
tored. The angioplasty catheter was then exchanged 
for the wedge catheter. Complete right- and left-sided 
heart hemodynamic values and a repeat left ventricu- 
Jar angiogram indicated a reduction in left atrial and 
pulmonary artery pressure without an increase in mi- 
tral regurgitation (Table I, Fig. 1). The patient was 
discharged from the hospital the next day. On her 
most recent clinic visit, 15 months after angioplasty, 
she reported a definite improvement in her symp- 
toms. Her exercise tolerance on the treadmill (Bruce 
FIGURE 1. Left atrlal (LA), left ventricular (LV) and 
pulmonary artery (PA) pressures from patlent 1 
before and after angloplasty. 
protocol) improved from 9 minutes to 11.5 minutes, 
with an increase in maximal heart rate response (80 to 
171 beats/min vs 86 to 184 beats/minj. In addition, the 
chest pain, which had been present during stages II 
and III of the prior treadmill, was no longer observed. 
She has also continued to show hemodynamic im- 
provement of MS as assessed by Doppler examina- 
tions under resting conditions and similar heart rate 
(Table II). 
Case 2: B.S., a l&year-old girl with a repaired co- 
arctation of the aorta, had mild subaortic stenosis and 
severe congenital MS. Because of severe dyspnea, 
March 20, 1985 she underwent cardiac catheteriza- 
tion, which revealed severe MS and pulmonary ar- 
tery hypertension (Table I], Balloon angioplasty was 
performed. The technique was identical to that de- 
scribed for case I, except that a E-mm angioplasty 
balloon was used. Two months after angioplasty there 
has been mild improvement in symptoms and contin- 
ued hemodynamic improvement documented on 
Doppler examination3 under resting conditions and a 
similar heart rate (Table II). 
Case 3: K.K., a .&year-old boy, had severe congeni- 
tal MS, coarctation of the aorta, patent ductus, left 
ventricular hypoplasia, subaortic stenosis and severe 
pulmonary artery hypertension. Because of severe ex- 
ercise intolerance and differential cyanosis, mitral 
valve angioplasty was attempted on October 27, 1984. 
Using the aforementioned technique, a 12-mm angio- 
plasty catheter was advanced across the atrial septum 
and into the left atrium. The catheter could not be 
advanced across the mitral valve, and angioplasty 
could not be performed. Two months after the at- 
tempted angioplasty a large left atrial thrombus was 
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identified and because of increasing symptoms surgi- 
cal removal of the thrombus was attempted. The child, 
however, died from sepsis 2 months later. We do not 
know if the left atria1 thrombus was related to the 
transseptal puncture, angioplasty balloon manipula- 
tion, low blood flow or polycythemia. 
To our knowledge, this is only the second report of 
the use of balloon angioplasty to treat rheumatic MS 
and the first report of its use to treat congenital MS. In 
the 2 patients in whom we successfully performed mi- 
tral valvuloplasty, left atria1 and pulmonary artery 
pressures decreased significantly and mitral valve 
area increased significantly, without any increase in 
mitral regurgitation. In addition, follow-up of 2 and 15 
months has shown both clinical and hemodynamic 
improvement. Our results are similar to those previ- 
ously reported by Inoue et al3 and suggest hat balloon 
angioplasty is feasible in both rheumatic and congeni- 
tal MS. Despite these results 2 additional technical 
obstacles must still be overcome. First, although for an 
individual patient the ideal size of the angioplasty bal- 
loon is unknown, based on our experience with pul- 
monary stenosis4 we believe a balloon approximately 
the size of the mitral anulus should be used. Only a 2O- 
mm balloon was used in case 1, since this was the 
largest size available. Had we used a larger balloon or, 
possibly 2 balloons side-by-side, a better result might 
have been achieved. Second, it was impossible to ma- 
nipulate the large stiff angioplasty balloon across the 
stenotic mitral valve in case 3. It is conceivable that 
either with the aid of a large (12 to 15Fr) sheath or using 
a precurved catheter that it might have been possible 
to perform angioplasty in this patient. Although mitral 
valve angioplasty is, at present, an experiinental pro- 
cedure, if these technical problems can be solved, it is 
likely that balloon angioplasty may be an alternative 
for selected patients with MS to surgical mitral 
commissurotomy. 
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Comparison of Supine and left 
lateral Decubitus Positions 
on M-Mode Echocardiographic 
Findings in Mitral Valve 
Prolapse by Auscultation 
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M -mode echocardiography has been the most fre- 
quently used tool in confirming the diagnosis of mitral 
valve prolapse (MVP] in suspected patients. Insensi- 
tive or false-negative results in M-mode studies have 
been reported192 and a provocative maneuver, such as 
postural change from the supine to standing position, 
has been reported to overcome the false-negative re- 
sults.2 There have been no reports to indicate that posi- 
tional changes even within the recumbent position 
could change the results of M-mode echocardiogra- 
phy. In some patients who had auscultatory evidence 
of MVP, we found that apparently or equivocally neg 
ative results on M-mode study in the left lateral posi- 
tion became positive in the supine position. These se- 
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lected patients were the subjects for further evaluation 
in this study. 
Sixteen patients who met the M-mode criteria for 
MVP only in the supine position were selected for 
further evaluation. In addition, 10 patients without 
auscultatory evidence of MVP served as a control 
group. Clinical profiles of these 16 selected patients, 
including the presence or absence of midsystolic click 
or systolic murmur are listed in Table I. Left ventricu- 
TABLE I M-mode Echocardlographlc Findings and Patlent Data 
M-Mode Echo LVEW (mm) 
Age W) Left Len 
Pt. & sex Supine Lateral Supine Lateral Click Murmur 
i 1 15F + f 43 46 + + 
2 16F + 0 47 49 + + 
3 17F + f 47 50 + 0 
4 20F + f 40 44 0 + 
5 21F + * 45 45 0 + 
6 21F + 0 49 49 + + 
7 24F + 0 40 40 + + 
8 25F + f 43 43 0 + 
9 27M + 0 46 46 + 0 
10 26F + 0 49 52 0 + 
11 3iF + f 47 49 + + 
12 32M + * 46 49 + 0 
13 33M + 0 46 49 + + 
14 36F + f 43 47 -I- O 
15 46M + 0 47 46 -t 0 
16 54F + f 50 54 0 + 
Mea” 45.6 47.5 
fSEM & 0.9 f 0.9 (p <O.OOl) 
Echo = echocardlography; LVEDIJ = left ventricular end-diastolic dimen- 
sion: SEM = standard error of the mean; + = positive: 0 = negative. 
